Position in NAMS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$5,101,766
+$3,429,980 QoQ
Shares Held
150,539
+188.2% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#64
of 197 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mizuho Markets Cayman LP holds $70,418,081 across 2 Biotechnology names. NAMS ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
834,500 | $65,316,315 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
150,539 | $5,101,766 |
All Filings in NAMS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,101,766 | 150,539 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $1,671,786 | 52,227 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,679,595 | 47,879 | Shares | Defined | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||